Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 24, 2025

SELL
$145.57 - $178.99 $15,284 - $18,793
-105 Closed
0 $0
Q1 2021

May 11, 2021

SELL
$249.67 - $299.48 $3,245 - $3,893
-13 Reduced 11.02%
105 $30,000
Q3 2020

Nov 12, 2020

BUY
$175.56 - $226.45 $20,716 - $26,721
118 New
118 $26,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.93B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track First Horizon Corp Portfolio

Follow First Horizon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Corp, based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Corp with notifications on news.